News Feed Opinion Career Insight Dialogues Blog Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
How risky is a second allogeneic stem cell transplantation? by Prof. Olaf Penack – IACH
Photo of Olaf Penack taken from haema-onko-cvk.charite.de
Aug 27, 2024, 23:15

How risky is a second allogeneic stem cell transplantation? by Prof. Olaf Penack – IACH

The International Academy for Clinical Hematology (IACH) shared on X:

“Hear the latest IACH News:

How risky is a second allogeneic stem cell transplantation? by Prof. Olaf Penack.”

Stem cell transplantation

Source: IACH/X

cancer Haematology IACH Olaf Penack OncoDaily Oncology
Blog
Aug 27, 2024, 23:15
How risky is a second allogeneic stem cell transplantation? by Prof. Olaf Penack - IACH
Societies
Aug 27, 2024, 23:12
SIOPE BTG European Combined Neuro-Oncology Course - AIEOP
Societies
Aug 27, 2024, 23:11
The breakthroughs of medical innovation within 38 European countries - SIOP Europe
Blog
Aug 27, 2024, 23:09
Juliana Beal: Our ETAC-S paper was published in Annals of Oncology
Blog
Aug 27, 2024, 23:08
Biggest medical discoveries of the week by Samuel Hume
Blog
Aug 27, 2024, 23:06
Al-Ola A Abdallah: What's the best approach after M protein reappearance in high-risk Smoldering Myeloma?
Societies
Aug 27, 2024, 23:05
Stephen Oh: Grateful for the opportunity to share our latest research at MPN Workshop NC24
Blog
Aug 27, 2024, 23:03
Jan-Henning Klusmann: Thrilled to be part of the newly published 'Acute Myeloid Leukemia in Children'
Insight
Aug 27, 2024, 23:00
The shift from ADT monotherapy to triple therapy in mHSPC - UroToday
Drugs
Aug 27, 2024, 22:44
Yan Leyfman: Umoja Biopharma has developed an in situ CAR- therapy
Drugs
Aug 27, 2024, 22:42
Maria Babak: Approval of axatilimab-csfr is a significant development in the treatment of cGVHD
Insight
Aug 27, 2024, 22:40
Raul Cordoba: CART cell therapy is a feasible treatment option for older patients with lymphoma